Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/1993
03/24/1993EP0533199A2 Application to a chimeric antibody directed against ganglioside GD3
03/24/1993EP0533006A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
03/24/1993EP0532979A2 Peptides for the preparation of means for diagnosis and therapy of systemic lupus
03/24/1993EP0532915A2 Phosphoinositolglycan-peptide with insulin like activity
03/24/1993EP0532673A1 Immunoassays for anti-hiv-1 antibodies
03/24/1993EP0532587A1 Methods for trans-destabilization of specific proteins in vivo
03/24/1993EP0532525A1 New protein-polycation conjugates.
03/24/1993EP0345315B1 Ps2 protein derivative
03/24/1993EP0312540B1 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
03/24/1993EP0248040B1 Ricin-antibody conjugates
03/24/1993EP0211894B1 Fsh
03/24/1993EP0180603B1 Rotavirus
03/24/1993EP0134799B1 Expression of plasmodium falciparum polypeptides from cloned cdna
03/24/1993CN1070227A DNA sequences encoding gelonin polypeptide
03/24/1993CA2078801A1 Enzymatically inactive phospholipase d of corynebacterium pseudotuberculosis
03/23/1993US5196516 Pseudorabies virus vaccine
03/23/1993US5196511 Peptides and antibodies that inhibit integrin-ligand binding
03/23/1993US5196337 Human monoclonal antibody, and its production and use
03/23/1993US5196324 Monoclonal antibodies reactive with a human atheroma associated antigen
03/23/1993US5196321 Methods for in vitro cleavage of ubiquitin fusion proteins
03/23/1993US5196319 Primary biliary cirrhosis autoantigen
03/23/1993US5196317 Overexpression of proteins in recombinant host cells
03/23/1993US5196316 Enzyme and dna coding therefor
03/23/1993US5196309 Blood disorders
03/23/1993US5196308 Methods for identifying the DQw3.2 allele associated with increased risk of insulin-dependent diabetes mellitus
03/23/1993CA1314831C Extraction of human interleukin-4 from bacteria
03/23/1993CA1314830C Bar1 secretion signal
03/23/1993CA1314811C Methods for identifying alleles associated with increased risk of diabetes
03/21/1993WO1993005811A1 A hepatitis b vaccine formulation incorporating a bile acid salt
03/21/1993CA2096650A1 Hepatitis b vaccine formulation incorporating a bile acid salt
03/21/1993CA2078358A1 Multivalent hepatitis b virus vaccine
03/19/1993CA2078384A1 Chimaeric interleukin 5-receptor/immunoglobulin polypeptides
03/18/1993WO1993005169A1 Hybrid cytokines
03/18/1993WO1993005168A1 Dna sequences encoding gelonin polypeptide
03/18/1993WO1993005166A1 Methods for the selection, separation and fusion of cells
03/18/1993WO1993005153A1 Biocidal proteins
03/18/1993WO1993005150A1 Collagen-induced platelet aggregation inhibitor
03/18/1993WO1993005148A1 Mutated growth factor receptor as medicament and its use for treating cancer
03/18/1993WO1993005146A1 Molecules with antibody combining sites that induce asymmetry
03/18/1993WO1993005145A1 Cell culture process and medium for the growth of adherent animal cells
03/18/1993WO1993005072A1 Disease associated human autoantibodies specific for human thyroid peroxidase
03/18/1993WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS
03/18/1993WO1993005070A1 Peptide inhibitors of inflammation mediated by selectins
03/18/1993WO1993005061A1 Cloning and characterization of a cardiac adenylyl cyclase
03/18/1993WO1993004695A1 T cell receptor-based therapy for rheumatoid arthritis
03/18/1993WO1993004586A1 Biocidal proteins
03/18/1993WO1992012992A3 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
03/18/1993CA2118707A1 Molecules with antibody combining sites that induce asymmetry
03/18/1993CA2118695A1 Peptide inhibitors of inflammation mediated by selectins
03/18/1993CA2117174A1 Collagen-induced platelet aggregation inhibitor
03/18/1993CA2117073A1 Mutated growth factor receptor as a drug and its use for the treatment of cancer
03/18/1993CA2117070A1 Methods for the selection, separation and fusion of cells
03/18/1993CA2116541A1 Biocidal proteins
03/18/1993CA2116533A1 Hybrid cytokines
03/18/1993CA2116526A1 T cell receptor-based therapy for rheumatoid arthritis
03/18/1993CA2116453A1 Disease associated human autoantibodies specific for human thyroid peroxidase
03/17/1993EP0532430A1 Reagent to identify bacteria of the species Staphylococcus aureus
03/17/1993EP0532359A1 Method of distinguishing cells
03/17/1993EP0532167A2 Non-A, Non-B Hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
03/17/1993EP0532090A2 Cellular immunity vaccines from bacterial toxin-antigen conjugates
03/17/1993EP0532043A2 Factor Xa linker DNA
03/17/1993EP0531728A1 HSV gD2 Baculovirus expression system
03/17/1993EP0531530A1 Process for producing protein
03/17/1993EP0531472A1 Humanized and chimeric monoclonal antibodies
03/17/1993EP0531434A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity
03/17/1993EP0531407A1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity
03/17/1993EP0317641B1 Fused protein containing lymphotoxin
03/17/1993EP0238631B1 Immunoassay method and kit
03/16/1993US5194596 Production of vascular endothelial cell growth factor
03/16/1993US5194595 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
03/16/1993US5194585 Vasoactive peptides
03/16/1993US5194425 Mhc-mediated toxic conjugates useful in ameliorating autoimmunity
03/16/1993US5194381 Plasmids and DNA coding for proteins
03/16/1993US5194377 Antibiotic agent
03/16/1993CA2064091C Diagnosis for porcine malignant hyperthermia
03/15/1993EP0594576A4 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products.
03/14/1993CA2078087A1 Hsv gd2 baculovirus expression system
03/11/1993DE4129533A1 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs A mutant growth factor receptor as a medicament and its use for treatment of cancer
03/10/1993EP0531204A1 Purified enzymatic preparation from chromobacterium violaceum, process to obtain it and its use in the production of alpha, beta-dehydrotryptophanyl peptides
03/10/1993EP0531187A1 Yeast promotor and its use
03/10/1993EP0531181A1 Highly stable recombinant yeasts for the production of recombinant proteins
03/10/1993EP0531104A2 Process for producing a lipoprotein-containing substance having a reduced lipid content
03/10/1993EP0530992A2 Enzymatic deprotection of peptides
03/10/1993EP0530937A1 Collagen-induced platelet aggregation inhibitor
03/10/1993EP0530765A2 Gene expression regulatory DNA
03/10/1993EP0530447A2 Process for purifying IgG monoclonal antibodies and their use
03/10/1993EP0530365A1 Human protein c expression vector
03/10/1993EP0530265A1 Dna encoding human 5-ht 1d? receptors and uses thereof
03/10/1993EP0489149A4 Probes for detecting mutant p53
03/10/1993EP0341302B1 Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor
03/10/1993EP0315650B1 Purification of recombinant interleukin-1
03/10/1993EP0233289B1 Hybridomas producing anti-pseudomonas aeruginosa human monoclonal antibody
03/10/1993CN1069737A Insulin analogs
03/10/1993CA2077277A1 Cellular immunity vaccines from bacterial toxin-antigen conjugates
03/09/1993US5192694 Anticoagulant, purification by adsorption on support, immunoadsorbent
03/09/1993US5192685 Bifidobacterium strains having high iga induction potential
03/09/1993US5192684 Human IgG1 monoclonal antibody specific for the nicotinic acetylcholine receptor and hybridoma producing the antibody
03/09/1993US5192668 Synthesis of protease inhibitor
03/09/1993US5192662 Anti-ganglioside GD1 A monoclonal antibody MZ, MZ-producing cells and MZ-containing reagent
03/09/1993CA1314254C Enzymatic membrane method for the synthesis and separation of peptides